Raquel N Faradji
Overview
Explore the profile of Raquel N Faradji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Ozairi E, Steenackers N, Pazmino S, Alattar A, Al Kandari J, Almeda-Valdes P, et al.
EClinicalMedicine
. 2024 Oct;
77:102869.
PMID: 39416388
Background: Individuals with type 1 diabetes (T1D) are traditionally perceived as lean, but recent evidence suggests an increasing trend of obesity. To provide global estimates, this study explored the prevalence...
2.
Gomez A, Carrillo D, Re M, Faradji R, Flores Caloca O, de la Garza Hernandez N, et al.
Diabetol Metab Syndr
. 2024 Jun;
16(1):128.
PMID: 38867297
Background: Continuous glucose monitoring can improve glycemic control for hospitalized patients with diabetes, according to current evidence. However, there is a lack of consensus-established recommendations for the management of hospitalized...
3.
Krakauer M, Gomez A, Almeda-Valdes P, Manrique H, Ruiz Morosini M, Godoy Jorquera G, et al.
Diabetol Metab Syndr
. 2024 May;
16(1):106.
PMID: 38769575
Objective: To establish recommendations through the consensus of a Latin American experts panel on the use of the flash glucose monitoring system (fCGM) in people living with type 2 diabetes...
4.
Ibarra-Salce R, Pozos-Varela F, Martinez-Zavala N, Lam-Chung C, Mena-Ureta T, Janka-Zires M, et al.
Endocr Pract
. 2023 Jan;
29(3):162-167.
PMID: 36627022
Objective: HbA1C is the "gold standard" parameter to evaluate glycemic control in diabetes; however, its correlation with mean glucose is not always perfect. The objective of this study was to...
5.
Van der Schueren B, Ellis D, Faradji R, Al-Ozairi E, Rosen J, Mathieu C
Lancet Diabetes Endocrinol
. 2021 Oct;
9(11):776-785.
PMID: 34600607
Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that...
6.
Antonio-Villa N, Garcia-Tuomola A, Almeda-Valdes P, Vidrio-Velazquez M, Islas-Ortega L, Madrigal-Sanroman J, et al.
Diabetes Res Clin Pract
. 2021 Sep;
180:109038.
PMID: 34487758
Aims: Type 1 diabetes (T1D) is a growing chronic disease. Evidence of whether the healthcare setting affects management and glycemic control is scarce. We evaluate outcomes in patients with T1D...
7.
Faradji R, Valenzuela-Lara M, Vidrio-Velazquez M, Yepez-Rodriguez A, Gonzalez-Galvez G, Sainz de la Maza-Viadero M
Salud Publica Mex
. 2020 Jun;
62(3):232-234.
PMID: 32520478
No abstract available.
8.
Faradji R, Froud T, Messinger S, Monroy K, Pileggi A, Mineo D, et al.
Cell Transplant
. 2009 Dec;
18(10):1247-59.
PMID: 20003758
The initial success of islet transplantation (ITx) is followed by graft dysfunction (GDF) and insulin reintroduction. Exenatide, a GLP-1 agonist, increases insulin and decreases glucagon secretion and has potential for...
9.
Gorn L, Faradji R, Messinger S, Monroy K, Baidal D, Froud T, et al.
J Diabetes Sci Technol
. 2009 Nov;
2(2):221-8.
PMID: 19885346
Background: This study evaluated the effects of islet allotransplantation (ITx) on metabolic control utilizing a continuous glucose monitoring system (CGMS) and assessed its effectiveness as an indicator and predictor of...
10.
Baidal D, Faradji R, Messinger S, Froud T, Monroy K, Ricordi C, et al.
Transplantation
. 2009 Mar;
87(5):689-97.
PMID: 19295313
Background: Islet transplantation can restore normoglycemia to patients with unstable type 1 diabetes mellitus, but long-term insulin independence is usually not sustained. Identification of predictor(s) of islet allograft dysfunction (IGD)...